Stock Analysts’ updated eps estimates for Friday, January 17th:
Absci (NASDAQ:ABSI) had its buy rating reissued by analysts at HC Wainwright. They currently have a $7.00 price target on the stock.
Antero Resources (NYSE:AR) had its hold rating reiterated by analysts at Benchmark Co..
Bruker (NASDAQ:BRKR) had its buy rating reaffirmed by analysts at Guggenheim.
Cabaletta Bio (NASDAQ:CABA) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $25.00 price target on the stock.
Cardlytics (NASDAQ:CDLX) had its hold rating reiterated by analysts at Needham & Company LLC.
Core Scientific (NASDAQ:CORZ) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $18.00 target price on the stock.
Charles River Laboratories International (NYSE:CRL) had its neutral rating reaffirmed by analysts at UBS Group AG. The firm currently has a $185.00 price target on the stock, down from their previous price target of $250.00.
Cryoport (NASDAQ:CYRX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $11.00 target price on the stock.
First Horizon (NYSE:FHN) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $24.00 price target on the stock.
Genius Sports (NYSE:GENI) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $12.00 price target on the stock.
H&E Equipment Services (NASDAQ:HEES) had its neutral rating reissued by analysts at UBS Group AG. UBS Group AG currently has a $92.00 target price on the stock, up from their previous target price of $60.00.
IMAX (NYSE:IMAX) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $30.00 price target on the stock.
IMAX (NYSE:IMAX) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $32.00 target price on the stock.
Infosys (NYSE:INFY) had its neutral rating reiterated by analysts at Guggenheim.
Innate Pharma (NASDAQ:IPHA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $11.50 target price on the stock.
J.B. Hunt Transport Services (NASDAQ:JBHT) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $205.00 price target on the stock.
J.B. Hunt Transport Services (NASDAQ:JBHT) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $195.00 target price on the stock.
JetBlue Airways (NASDAQ:JBLU) had its underperform rating reiterated by analysts at Bank of America Co.. Bank of America Co. currently has a $6.50 target price on the stock.
Kaltura (NASDAQ:KLTR) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $3.00 price target on the stock.
Keros Therapeutics (NASDAQ:KROS) had its neutral rating reaffirmed by analysts at Guggenheim.
Life Time Group (NYSE:LTH) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $32.00 target price on the stock, up from their previous target price of $29.00.
Lucky Strike Entertainment (NYSE:LUCK) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a $12.00 target price on the stock, down from their previous target price of $15.00.
Southwest Airlines (NYSE:LUV) had its underperform rating reaffirmed by analysts at Bank of America Co.. The firm currently has a $31.00 price target on the stock, down from their previous price target of $33.00.
Montrose Environmental Group (NYSE:MEG) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $39.00 target price on the stock.
Magnite (NASDAQ:MGNI) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $20.00 target price on the stock.
M&T Bank (NYSE:MTB) had its buy rating reaffirmed by analysts at Truist Financial Co.. Truist Financial Co. currently has a $236.00 price target on the stock, up from their previous price target of $233.00.
Matador Resources (NYSE:MTDR) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $62.00 target price on the stock.
Norwegian Cruise Line (NYSE:NCLH) had its outperform rating reiterated by analysts at Macquarie. They currently have a $30.00 price target on the stock.
Nuvalent (NASDAQ:NUVL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $110.00 price target on the stock.
Omeros (NASDAQ:OMER) had its hold rating reissued by analysts at Needham & Company LLC.
Outlook Therapeutics (NASDAQ:OTLK) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $30.00 price target on the stock.
Outlook Therapeutics (NASDAQ:OTLK) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $12.00 target price on the stock.
Bank OZK (NASDAQ:OZK) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $53.00 target price on the stock.
Planet Labs PBC (NYSE:PL) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $5.00 price target on the stock.
The PNC Financial Services Group (NYSE:PNC) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $200.00 price target on the stock.
Progress Software (NASDAQ:PRGS) had its buy rating reissued by analysts at Guggenheim. They currently have a $83.00 target price on the stock.
Polestar Automotive Holding UK (NASDAQ:PSNY) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald.
RADCOM (NASDAQ:RDCM) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $16.00 price target on the stock.
Radware (NASDAQ:RDWR) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Rapid7 (NASDAQ:RPD) had its hold rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $42.00 target price on the stock, down from their previous target price of $48.00.
Range Resources (NYSE:RRC) had its hold rating reiterated by analysts at Benchmark Co..
Revance Therapeutics (NASDAQ:RVNC) had its hold rating reissued by analysts at Needham & Company LLC.
Spotify Technology (NYSE:SPOT) had its peer perform rating reaffirmed by analysts at Wolfe Research.
Symbotic (NASDAQ:SYM) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $35.00 price target on the stock.
Taboola.com (NASDAQ:TBLA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $5.00 target price on the stock.
Target (NYSE:TGT) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $150.00 price target on the stock.
Udemy (NASDAQ:UDMY) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $11.00 price target on the stock.
UnitedHealth Group (NYSE:UNH) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $700.00 price target on the stock.
UnitedHealth Group (NYSE:UNH) had its overweight rating reissued by analysts at KeyCorp. KeyCorp currently has a $650.00 target price on the stock.
Upwork (NASDAQ:UPWK) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $17.00 target price on the stock.
Veeva Systems (NYSE:VEEV) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $270.00 target price on the stock.
Viking Therapeutics (NASDAQ:VKTX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $102.00 target price on the stock.
V2X (NYSE:VVX) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $80.00 target price on the stock.
WaFd (NASDAQ:WAFD) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $38.00 target price on the stock.
Western Digital (NASDAQ:WDC) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $95.00 price target on the stock.
Warby Parker (NYSE:WRBY) had its in-line rating reiterated by analysts at Evercore ISI. The firm currently has a $23.00 target price on the stock.
Receive News & Ratings for Absci Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci Co and related companies with MarketBeat.com's FREE daily email newsletter.